{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:04:50Z","timestamp":1785463490644,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T00:00:00Z","timestamp":1317600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant vascular disorder, characterized by recurrent epistaxis, mucocutaneous telangiectases, and arteriovenous malformations (AVMs) in various visceral organs. Endoglin (<jats:italic>ENG<\/jats:italic>) and activin receptor-like kinase 1 (<jats:italic>ACVRL1; ALK1<\/jats:italic>), receptors for transforming growth factor-\u03b2 (TGF-\u03b2) superfamily, have been identified as the principal HHT-causing genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Three unrelated Korean HHT patients and their asymptomatic as well as symptomatic family members were genetically diagnosed by sequencing whole exons and their flanking regions of <jats:italic>ENG<\/jats:italic> and <jats:italic>ACVRL1<\/jats:italic>. Functionality of an aberrant translation start codon, which is created by a substitution mutation at the 5'-untranslated region (UTR) of <jats:italic>ENG<\/jats:italic> found in a HHT family, was tested by transient <jats:italic>in vitro<\/jats:italic> transfection assay. Decay of the mutant transcripts was also assessed by allele-specific expression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Two <jats:italic>ENG<\/jats:italic> and one <jats:italic>ACVRL1<\/jats:italic> mutations were identified: a known <jats:italic>ENG<\/jats:italic> mutation (c.360+1G &gt; A; p.Gly74_Tyr120del); a novel <jats:italic>ENG<\/jats:italic> mutation (c.1-127C &gt; T); and a novel <jats:italic>ACVRL1<\/jats:italic> mutation (c.252_253insC; p.Val85fsX168). We further validated that the 5'-UTR <jats:italic>ENG<\/jats:italic> mutation prevents translation of ENG from the biological translation initiation site of the mutant allele, and leads to degradation of the mutant transcripts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first experimental demonstration that a 5'-UTR mutation can prevent translation of ENG among HHT patients, and further supports the previous notion that haploinsufficiency is the primary mechanism of HHT1. Our data also underscore the importance of including exons encoding 5' UTR for HHT mutation screening.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-12-130","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T18:30:56Z","timestamp":1319653856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia"],"prefix":"10.1186","volume":"12","author":[{"given":"Mi-Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung-Doo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Bom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk P","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,3]]},"reference":[{"key":"862_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","volume":"24","author":"CL Shovlin","year":"2010","unstructured":"Shovlin CL: Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24: 203-219. 10.1016\/j.blre.2010.07.001.","journal-title":"Blood Rev"},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A: Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999, 245: 31-39. 10.1046\/j.1365-2796.1999.00398.x.","journal-title":"J Intern Med"},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.10026","volume":"19","author":"M Dakeishi","year":"2002","unstructured":"Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A: Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002, 19: 140-148. 10.1002\/humu.10026.","journal-title":"Hum Mutat"},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M: Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006, 43: 97-110.","journal-title":"J Med Genet"},{"key":"862_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2174\/138161206776361291","volume":"12","author":"GM Lenato","year":"2006","unstructured":"Lenato GM, Guanti G: Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects. Curr Pharm Des. 2006, 12: 1173-1193. 10.2174\/138161206776361291.","journal-title":"Curr Pharm Des"},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al: Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994, 8: 345-351. 10.1038\/ng1294-345.","journal-title":"Nat Genet"},{"key":"862_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0294-197","volume":"6","author":"MT McDonald","year":"1994","unstructured":"McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecker BB, Helmbold EA, Markel DS, Zolotor A, McKinnon WC, Vanderstoep JL, et al: A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet. 1994, 6: 197-204. 10.1038\/ng0294-197.","journal-title":"Nat Genet"},{"key":"862_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng0294-205","volume":"6","author":"CL Shovlin","year":"1994","unstructured":"Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J, Seidman CE, Seidman JG: A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994, 6: 205-209. 10.1038\/ng0294-205.","journal-title":"Nat Genet"},{"key":"862_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/hmg\/4.5.945","volume":"4","author":"P Vincent","year":"1995","unstructured":"Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J: A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet. 1995, 4: 945-949. 10.1093\/hmg\/4.5.945.","journal-title":"Hum Mol Genet"},{"key":"862_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, et al: Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996, 13: 189-195. 10.1038\/ng0696-189.","journal-title":"Nat Genet"},{"key":"862_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/gr.5.1.21","volume":"5","author":"DW Johnson","year":"1995","unstructured":"Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteous ME, Marchuk DA: A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res. 1995, 5: 21-28. 10.1101\/gr.5.1.21.","journal-title":"Genome Res"},{"issue":"6","key":"862_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/humu.9421","volume":"27","author":"G Lesca","year":"2006","unstructured":"Lesca G, Burnichon N, Raux G, Tosi M, Pinson S, Marion MJ, Babin E, Gilbert-Dussardier B, Riviere S, Goizet C, et al: Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Human mutation. 2006, 27 (6): 598-","journal-title":"Human mutation"},{"issue":"7","key":"862_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL: Hereditary haemorrhagic telangiectasia: a clinical and scientific review. European journal of human genetics: EJHG. 2009, 17 (7): 860-871. 10.1038\/ejhg.2009.35.","journal-title":"European journal of human genetics: EJHG"},{"key":"862_CR14","unstructured":"HHT Mutation Database. Database Last Updated: 09\/19\/2009, [http:\/\/www.hhtmutation.org\/index.php]"},{"issue":"7","key":"862_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG, Begbie ME, Wallace GM, Shovlin CL: A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. Journal of medical genetics. 2005, 42 (7): 577-582. 10.1136\/jmg.2004.028712.","journal-title":"Journal of medical genetics"},{"issue":"20","key":"862_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ajmg.a.31450","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R: A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. American journal of medical genetics. 2006, 140 (20): 2155-2162.","journal-title":"American journal of medical genetics"},{"issue":"9412","key":"862_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA: A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004, 363 (9412): 852-859. 10.1016\/S0140-6736(04)15732-2.","journal-title":"Lancet"},{"issue":"8","key":"862_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ, Bailly S: Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circulation research. 2008, 102 (8): 914-922. 10.1161\/CIRCRESAHA.107.165530.","journal-title":"Circulation research"},{"issue":"9","key":"862_CR19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2010-03-276881","volume":"116","author":"N Ricard","year":"2010","unstructured":"Ricard N, Bidart M, Mallet C, Lesca G, Giraud S, Prudent R, Feige JJ, Bailly S: Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations. Blood. 2010, 116 (9): 1604-1612. 10.1182\/blood-2010-03-276881.","journal-title":"Blood"},{"issue":"5","key":"862_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S: Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood. 2007, 109 (5): 1953-1961. 10.1182\/blood-2006-07-034124.","journal-title":"Blood"},{"issue":"1","key":"862_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3346\/jkms.2009.24.1.69","volume":"24","author":"ST Lee","year":"2009","unstructured":"Lee ST, Kim JA, Jang SY, Kim DK, Do YS, Suh GY, Kim JW, Ki CS: Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia. Journal of Korean medical science. 2009, 24 (1): 69-76. 10.3346\/jkms.2009.24.1.69.","journal-title":"Journal of Korean medical science"},{"issue":"1","key":"862_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 91 (1): 66-67. 10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P.","journal-title":"Am J Med Genet"},{"key":"862_CR23","doi-asserted-by":"crossref","unstructured":"Spandidos A, Wang X, Wang H, Seed B: PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic acids research. 2010, D792-799. 38 Database","DOI":"10.1093\/nar\/gkp1005"},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/1471-2164-9-633","volume":"9","author":"A Spandidos","year":"2008","unstructured":"Spandidos A, Wang X, Wang H, Dragnev S, Thurber T, Seed B: A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics. 2008, 9: 633-10.1186\/1471-2164-9-633.","journal-title":"BMC Genomics"},{"issue":"24","key":"862_CR25","doi-asserted-by":"publisher","first-page":"e154.26","DOI":"10.1093\/nar\/gng154","volume":"31","author":"X Wang","year":"2003","unstructured":"Wang X, Seed B: A PCR primer bank for quantitative gene expression analysis. Nucleic acids research. 2003, 31 (24): e154.26-","journal-title":"Nucleic acids research"},{"issue":"1","key":"862_CR26","first-page":"62","volume":"9","author":"K-W Oh","year":"2007","unstructured":"Oh K-W, Chang W-Y, Kim H-Y, Koh S-H, Han G-S, Lee Y-J, Lee K-Y: A Case of Hereditary Hemorrhagic Telangiectasia Presented with Seizure. Korean J Stroke. 2007, 9 (1): 62-65.","journal-title":"Korean J Stroke"},{"issue":"3","key":"862_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1148\/radiol.2233010953","volume":"223","author":"HP Dinkel","year":"2002","unstructured":"Dinkel HP, Triller J: Pulmonary arteriovenous malformations: embolotherapy with superselective coaxial catheter placement and filling of venous sac with Guglielmi detachable coils. Radiology. 2002, 223 (3): 709-714. 10.1148\/radiol.2233010953.","journal-title":"Radiology"},{"issue":"10","key":"862_CR28","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1172\/JCI119800","volume":"100","author":"N Pece","year":"1997","unstructured":"Pece N, Vera S, Cymerman U, White RI, Wrana JL, Letarte M: Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. The Journal of clinical investigation. 1997, 100 (10): 2568-2579. 10.1172\/JCI119800.","journal-title":"The Journal of clinical investigation"},{"issue":"3","key":"862_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)80542-5","volume":"96","author":"MW Hentze","year":"1999","unstructured":"Hentze MW, Kulozik AE: A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999, 96 (3): 307-310. 10.1016\/S0092-8674(00)80542-5.","journal-title":"Cell"},{"issue":"3","key":"862_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20100699","volume":"430","author":"M Bhuvanagiri","year":"2010","unstructured":"Bhuvanagiri M, Schlitter AM, Hentze MW, Kulozik AE: NMD: RNA biology meets human genetic medicine. The Biochemical journal. 2010, 430 (3): 365-377. 10.1042\/BJ20100699.","journal-title":"The Biochemical journal"},{"issue":"7","key":"862_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/humu.20342","volume":"27","author":"AD Bossler","year":"2006","unstructured":"Bossler AD, Richards J, George C, Godmilow L, Ganguly A: Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Human mutation. 2006, 27 (7): 667-675. 10.1002\/humu.20342.","journal-title":"Human mutation"},{"issue":"1-2","key":"862_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(02)01056-9","volume":"299","author":"M Kozak","year":"2002","unstructured":"Kozak M: Pushing the limits of the scanning mechanism for initiation of translation. Gene. 2002, 299 (1-2): 1-34. 10.1016\/S0378-1119(02)01056-9.","journal-title":"Gene"},{"issue":"6","key":"862_CR33","first-page":"818","volume":"90","author":"H Sadick","year":"2005","unstructured":"Sadick H, Riedel F, Naim R, Goessler U, Hormann K, Hafner M, Lux A: Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica. 2005, 90 (6): 818-828.","journal-title":"Haematologica"},{"issue":"13","key":"862_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/hmg\/10.13.1347","volume":"10","author":"ME Paquet","year":"2001","unstructured":"Paquet ME, Pece-Barbara N, Vera S, Cymerman U, Karabegovic A, Shovlin C, Letarte M: Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Human molecular genetics. 2001, 10 (13): 1347-1357. 10.1093\/hmg\/10.13.1347.","journal-title":"Human molecular genetics"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-12-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:58:02Z","timestamp":1630515482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-12-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-12-130","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,3]]},"assertion":[{"value":"9 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"130"}}